Page last updated: 2024-08-25

oxazolidin-2-one and Dizziness

oxazolidin-2-one has been researched along with Dizziness in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Isildak, H; O'Connell Ferster, AP; Priesol, AJ1
Emeribe, U; Hee, A; Silberstein, S; Tuchman, M1
Diener, HC; Evers, S1
Cleary, EW; Huffman, CS; Polvino, WJ; Smith, DA; Watkins, S1
Antal, EJ; Batts, DH; Hendershot, PE; Hopkins, NK; Welshman, IR1

Reviews

1 review(s) available for oxazolidin-2-one and Dizziness

ArticleYear
The clinical manifestations of vestibular migraine: A review.
    Auris, nasus, larynx, 2017, Volume: 44, Issue:3

    Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Dizziness; Headache; Humans; Migraine Disorders; Oxazolidinones; Quality of Life; Serotonin 5-HT1 Receptor Agonists; Tryptamines; Vertigo; Vestibular Diseases

2017

Trials

4 trial(s) available for oxazolidin-2-one and Dizziness

ArticleYear
Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    CNS drugs, 2006, Volume: 20, Issue:12

    Topics: Acute Disease; Administration, Oral; Adult; Chest Pain; Dizziness; Double-Blind Method; Female; Humans; Menstruation Disturbances; Middle Aged; Migraine Disorders; Nausea; Oxazolidinones; Paresthesia; Patient Dropouts; Self Administration; Serotonin Receptor Agonists; Tablets; Treatment Outcome; Tryptamines

2006
Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study.
    Clinical drug investigation, 2007, Volume: 27, Issue:1

    Topics: Administration, Intranasal; Adult; Adverse Drug Reaction Reporting Systems; Cardiovascular Diseases; Dizziness; Female; Humans; Male; Middle Aged; Migraine with Aura; Migraine without Aura; Nausea; Oxazolidinones; Patient Satisfaction; Product Surveillance, Postmarketing; Serotonin Receptor Agonists; Surveys and Questionnaires; Treatment Outcome; Tryptamines

2007
Zolmitriptan (311C90) does not interact with fluoxetine in healthy volunteers.
    International journal of clinical pharmacology and therapeutics, 1998, Volume: 36, Issue:6

    Topics: Adolescent; Adult; Cranial Sinuses; Cross-Over Studies; Dizziness; Drug Interactions; Drug Tolerance; Female; Fluoxetine; Humans; Intracranial Pressure; Male; Middle Aged; Nausea; Oxazoles; Oxazolidinones; Patient Compliance; Pharyngitis; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Tryptamines

1998
Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr.
    Journal of clinical pharmacology, 2001, Volume: 41, Issue:5

    Topics: Acetamides; Adult; Area Under Curve; Blood Pressure; Body Temperature; Dextromethorphan; Dizziness; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Ephedrine; Female; Headache; Heart Rate; Humans; Linezolid; Male; Mental Processes; Middle Aged; Monoamine Oxidase Inhibitors; Nonprescription Drugs; Oxazolidinones; Phenylpropanolamine; Regression Analysis; Sympathomimetics

2001